DIARY-Today in Washington - April 15
ALL TIMES IN EDT/GMT
Venezuela's seeking of specific vaccines will slow inoculation, Guaido says
CARACAS (Reuters) - Venezuela is risking further delays to an already stalled COVID-19 vaccination campaign by seeking to use specific brands of vaccines while shunning readily available ones, opposition leader Juan Guaido said on Wednesday.
UPDATE 6-Cop who shot Black man after traffic stop arrested, charged with manslaughter
MINNEAPOLIS, April 14 (Reuters) - The white police officer whose fatal shooting of a young Black motorist during a traffic stop in a Minneapolis suburb ignited three nights of protests and civil unrest was arrested on Wednesday and charged with second-degree manslaughter.
UPDATE 3-NATO allies to leave Afghanistan along with U.S.
BRUSSELS/BERLIN, April 14 (Reuters) - Foreign troops under NATO command will withdraw from Afghanistan in coordination with a U.S. pull-out by Sept. 11, NATO allies agreed on Wednesday, pledging to mirror American plans to start removing troops on May 1 after two decades of war.
Germany, United States call on Russia to pull back troops from Ukrainian border
BERLIN, April 14 (Reuters) - German Chancellor Angela Merkel and U.S. President Joe Biden called on Russia to pull back troops from the Ukrainian border to de-escalate the situation in the region, a German government spokesman said on Wednesday.
UPDATE 2-Ford outlines further production cuts due to global chip shortage
DETROIT, April 14 (Reuters) - Ford Motor Co on Wednesday outlined another series of plant shutdowns due to the global semiconductor chip shortage, with five facilities in the United States and one in Turkey affected.
UPDATE 4-Coinbase valued at $83 bln in choppy Nasdaq debut
April 14 (Reuters) - Shares in Coinbase Global Inc had a choppy Nasdaq debut on Wednesday, with the cryptocurrency exchange's valuation swinging from as high as $112 billion to as low as $83 billion.
UPDATE 3-U.S. advisory panel reviews rare clot risk with J&J COVID-19 vaccine
WASHINGTON, April 14 (Reuters) - A U.S. health advisory panel on Wednesday began a review of six reported cases of rare blood clots in women who received Johnson & Johnson's COVID-19 vaccine, a day after federal regulators paused its use to assess the issue.
U.S. committed to assisting Ukraine with self defense needs- Austin
April 14 (Reuters) - U.S. Defense Secretary Lloyd Austin said on Wednesday that the United States would look to continue providing material support to Ukraine.
Moderna discusses COVID-19 vaccine manufacturing with Nexus Pharmaceuticals: sources
WASHINGTON (Reuters) - Moderna Inc, looking to boost production of its COVID-19 vaccine, met with Nexus Pharmaceuticals to discuss manufacturing the shot at the company's new plant in Wisconsin, which has the capacity to process and fill 30 million doses a month, sources with knowledge of the matter said.
- More News Headlines